In this video, the IMF’s Senior Director of Support Groups points out the number of new classes of myeloma drugs that are in the pipeline. From ASH 2016, she is able to go home to a support group she co-leads in Connecticut and share the viability of stem cell transplants for patients over the age of 65, based more on their fit v. frail status than their age. She closes this talk by extending her gratitude to the IMF, to the organization’s President and Founder Susie Novis Durie, and our pharmaceutical sponsors.